↓ Skip to main content

Comparison of heart failure risk and medical costs between patients with type 2 diabetes mellitus treated with dapagliflozin and dipeptidyl peptidase-4 inhibitors: a nationwide population-based…

Overview of attention for article published in Cardiovascular Diabetology, June 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
57 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Comparison of heart failure risk and medical costs between patients with type 2 diabetes mellitus treated with dapagliflozin and dipeptidyl peptidase-4 inhibitors: a nationwide population-based cohort study
Published in
Cardiovascular Diabetology, June 2020
DOI 10.1186/s12933-020-01060-1
Pubmed ID
Authors

Jong-Mi Seong, Jong Joo Kim, Hae Jin Kim, Hyun Soon Sohn

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 57 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 12%
Student > Master 6 11%
Researcher 5 9%
Student > Bachelor 5 9%
Student > Doctoral Student 4 7%
Other 6 11%
Unknown 24 42%
Readers by discipline Count As %
Medicine and Dentistry 16 28%
Pharmacology, Toxicology and Pharmaceutical Science 3 5%
Nursing and Health Professions 3 5%
Economics, Econometrics and Finance 2 4%
Social Sciences 2 4%
Other 4 7%
Unknown 27 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 June 2020.
All research outputs
#20,625,804
of 23,217,343 outputs
Outputs from Cardiovascular Diabetology
#1,253
of 1,418 outputs
Outputs of similar age
#341,892
of 399,722 outputs
Outputs of similar age from Cardiovascular Diabetology
#33
of 38 outputs
Altmetric has tracked 23,217,343 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,418 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 399,722 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.